| 股號 / 名稱 | 營收 | 稅後淨利 |
| AYTU Aytu Biopharma Inc | 13,888,000.0 | 1,965,000.0 |
| NTLA Intellia Therapeutics Inc | 13,782,000.0 | -101,324,000.0 |
| NRIX Nurix Therapeutics Inc | 13,577,000.0 | -78,221,000.0 |
| VYGR Voyager Therapeutics Inc | 13,365,000.0 | -27,892,000.0 |
| GOSS Gossamer Bio Inc | 13,294,000.0 | -48,221,000.0 |
| NUVB Nuvation Bio Inc | 13,120,000.0 | -55,792,000.0 |
| GLUE Monte Rosa Therapeutics Inc | 12,768,000.0 | -27,081,000.0 |
| RNA Avidity Biosciences Inc | 12,475,000.0 | -174,442,000.0 |
| BCYC Bicycle Therapeutics PLC | 11,734,000.0 | -59,100,000.0 |
| CHRS Coherus Oncology Inc | 11,571,000.0 | -44,517,000.0 |
| VSTM Verastem Inc | 11,242,000.0 | -98,518,000.0 |
| CCCC C4 Therapeutics Inc | 11,230,000.0 | -32,166,000.0 |
| STOK Stoke Therapeutics Inc | 10,632,000.0 | -38,347,000.0 |
| TKNO Alpha Teknova Inc | 10,454,000.0 | -4,286,000.0 |
| JANX Janux Therapeutics Inc | 10,000,000.0 | -24,313,000.0 |
| BEAM Beam Therapeutics Inc | 9,698,000.0 | -112,728,000.0 |
| STRO Sutro Biopharma Inc | 9,693,000.0 | -56,857,000.0 |
| SBFM Sunshine Biopharma Inc | 9,417,180.0 | -883,820.0 |
| XOMA Xoma Royalty Corp | 9,351,000.0 | 14,051,000.0 |
| ABCL Abcellera Biologics Inc | 8,955,000.0 | -57,119,000.0 |
| PTN Palatin Technologies Inc | 8,847,550.0 | 4,677,530.0 |
| CDXS Codexis Inc | 8,601,000.0 | -19,615,000.0 |
| WVE WAVE Life Sciences Ltd | 7,608,000.0 | -53,852,000.0 |
| EDIT Editas Medicine Inc | 7,543,000.0 | -25,117,000.0 |
| EVAX Evaxion A/S | 7,492,000.0 | 4,617,000.0 |
| BNGO Bionano Genomics Inc | 7,367,000.0 | -8,503,000.0 |
| BFRI Biofrontera Inc | 6,988,000.0 | -6,649,000.0 |
| MXCT MaxCyte Inc | 6,829,000.0 | -12,416,000.0 |
| IMTX Immatics NV | 6,087,359.46 | -59,318,601.1 |
| CTMX CytomX Therapeutics Inc | 5,963,000.0 | -14,229,000.0 |
| SPRO Spero Therapeutics Inc | 5,442,000.0 | -7,382,000.0 |
| CELU Celularity Inc | 5,284,000.0 | -23,076,000.0 |
| ACLX Arcellx Inc | 4,949,000.0 | -55,781,000.0 |
| PTGX Protagonist Therapeutics Inc | 4,712,000.0 | -39,339,000.0 |
| SEER Seer Inc | 4,121,000.0 | -18,234,000.0 |
| QURE Uniqure NV | 3,701,000.0 | -80,529,000.0 |
| LCTX Lineage Cell Therapeutics Inc | 3,681,000.0 | -29,752,000.0 |
| ATRA Atara Biotherapeutics Inc | 3,453,000.0 | -4,303,000.0 |
| PRQR ProQR Therapeutics NV | 3,420,985.7 | -12,916,421.48 |
| ALEC Alector Inc | 3,260,000.0 | -34,667,000.0 |
| CRIS Curis Inc | 3,176,000.0 | -7,729,000.0 |
| PGEN Precigen Inc | 2,922,000.0 | -146,344,000.0 |
| DBVT Dbv Technologies SA | 2,774,000.0 | -33,164,000.0 |
| KYMR Kymera Therapeutics Inc | 2,764,000.0 | -82,175,000.0 |
| TCRX TScan Therapeutics Inc | 2,511,000.0 | -35,710,000.0 |
| PRTA Prothena Corporation PLC | 2,415,000.0 | -36,541,000.0 |
| CRBU Caribou Biosciences Inc | 2,198,000.0 | -27,548,000.0 |
| BOLT Bolt Biotherapeutics Inc | 2,169,000.0 | -7,144,000.0 |
| CUE Cue Biopharma Inc | 2,149,000.0 | -7,448,000.0 |
| CYTK Cytokinetics Inc | 1,936,000.0 | -306,178,000.0 |
| CGEN Compugen Ltd | 1,891,000.0 | -6,979,000.0 |
| XAIR Beyond Air Inc | 1,818,000.0 | -8,258,000.0 |
| XFOR X4 Pharmaceuticals Inc | 1,765,000.0 | -29,815,000.0 |
| OCGN Ocugen Inc | 1,752,000.0 | -20,051,000.0 |
| FATE Fate Therapeutics Inc | 1,741,000.0 | -32,250,000.0 |
| TRDA Entrada Therapeutics Inc | 1,614,000.0 | -44,134,000.0 |
| ROIV Roivant Sciences Ltd | 1,571,000.0 | -166,039,000.0 |
| ACIU AC Immune SA | 1,179,571.8 | -19,920,819.6 |
| DYAI Dyadic International Inc | 1,164,620.0 | -1,976,010.0 |
| ARMP Armata Pharmaceuticals Inc | 1,159,000.0 | -26,675,000.0 |
| STTK Shattuck Labs Inc | 1,000,000.0 | -10,056,000.0 |
| EYPT EyePoint Inc | 966,000.0 | -59,732,000.0 |
| CRSP CRISPR Therapeutics AG | 889,000.0 | -106,441,000.0 |
| CYCN Cyclerion Therapeutics Inc | 875,000.0 | -976,000.0 |
| ABVC ABVC Biopharma Inc | 795,950.0 | -1,287,520.0 |
| PLAG Planet Green Holdings Corp | 771,640.0 | -3,421,710.0 |
| HUMA Humacyte Inc | 753,000.0 | -17,510,000.0 |
| ALGS Aligos Therapeutics Inc | 741,000.0 | -31,537,000.0 |
| FEMY Femasys Inc | 729,390.0 | -4,194,820.0 |
| VNRX VolitionRX Ltd | 627,280.0 | -5,409,790.0 |
| SGMO Sangamo Therapeutics Inc | 581,000.0 | -34,930,000.0 |
| ABUS Arbutus Biopharma Corp | 529,000.0 | -7,742,000.0 |
| ENSC Ensysce Biosciences Inc | 493,100.0 | -3,729,130.0 |
| MGTX MeiraGTx Holdings PLC | 410,000.0 | -50,513,000.0 |
| ABSI Absci Corp | 378,000.0 | -28,706,000.0 |
| MCRB Seres Therapeutics Inc | 351,000.0 | 8,204,000.0 |
| EVGN Evogene Ltd | 312,000.0 | -2,729,000.0 |
| RNXT RenovoRx Inc | 266,000.0 | -2,912,000.0 |
| VTGN Vistagen Therapeutics Inc | 258,000.0 | -19,417,000.0 |
| VIR Vir Biotechnology Inc | 240,000.0 | -163,141,000.0 |
| RLYB Rallybio Corp | 212,000.0 | 16,016,000.0 |
| LGVN Longeveron Inc | 137,000.0 | -7,221,000.0 |
| OVID Ovid Therapeutics Inc | 132,000.0 | -12,158,000.0 |
| MNOV MediciNova Inc | 123,320.0 | -3,050,370.0 |
| CRDF Cardiff Oncology Inc | 120,000.0 | -11,258,000.0 |
| IBIO iBio Inc | 100,000.0 | -5,720,000.0 |
| BTAI BioXcel Therapeutics Inc | 98,000.0 | -30,911,000.0 |
| CLGN Collplant Biotechnologies Ltd | 77,000.0 | -3,483,000.0 |
| IFRX InflaRx NV | 27,966.41 | -14,389,370.0 |
| HCWB HCW Biologics Inc | 15,610.0 | -4,554,340.0 |
| CLNN Clene Inc | 15,000.0 | -8,777,000.0 |
| DTIL Precision BioSciences Inc | 13,000.0 | -21,772,000.0 |
| BRTX BioRestorative Therapies Inc | 11,800.0 | -3,038,280.0 |
| DARE Dare Bioscience Inc | 2,260.0 | -3,562,770.0 |
| APRE Aprea Therapeutics Inc | 1,850.0 | -2,972,410.0 |
| TIL Instil Bio Inc | 0.0 | -13,587,000.0 |
| DSGN Design Therapeutics Inc | 0.0 | -16,997,000.0 |
| EWTX Edgewise Therapeutics Inc | 0.0 | -40,666,000.0 |
| BMEA Biomea Fusion Inc | 0.0 | -16,407,000.0 |
| PALI Palisade Bio Inc | 0.0 | -2,868,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰？
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例